Antibacterial Envelope Shows Low Infection Rate, High Implantation Success

Patients undergoing cardiac implantable electronic device implantation with TYRX, Inc’s FDA-cleared AIGISRx Antibacterial Envelope enjoyed a 99.5 percent rate of successful implantation with an overall infection rate of 0.48 percent in the first 1.9 months following the procedure, as reported in newly published results of TYRX’s COMMAND clinical study.
CNBC